During the past decade, Rockford Gastroenterology Associates LTD conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 11 clinical trials were completed, i.e. on average, 137.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rockford Gastroenterology Associates LTD" #1 sponsor was "Bausch Health Americas, Inc." with 3 trials, followed by "Exact Sciences Corporation" with 3 trials sponsored, "Eisai Inc." with 2 trials sponsored, "Epigenomics, Inc" with 2 trials sponsored and "Ferring Pharmaceuticals" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rockford Gastroenterology Associates LTD" #1 collaborator was "Ironwood Pharmaceuticals, Inc." with 2 trials as a collaborator, "Allergan Sales, LLC" with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator, "Premier Research Group plc" with 1 trials as a collaborator and "RTI Health Solutions" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Rockford Gastroenterology Associates LTD" are "Colorectal Cancer" (6 trials), "Chronic Idiopathic Constipation" (4 trials), "Irritable Bowel Syndrome" (4 trials), "Colonic Diseases" (3 trials) and "Colorectal Neoplasms" (3 trials). Many other conditions were trialed in "Rockford Gastroenterology Associates LTD" in a lesser frequency.

Most popular intervention types in "Rockford Gastroenterology Associates LTD" are "Drug" (20 trials), "Other" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "AQUAVAN® (fospropofol disodium) Injection" (2 trials), "Linaclotide" (2 trials), "APT-1011" (1 trials) and "All eligible subjects will provide blood for SEPT9 biomarker testing" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rockford Gastroenterology Associates LTD" are 26 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Rockford Gastroenterology Associates LTD". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Rockford Gastroenterology Associates LTD, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rockford Gastroenterology Associates LTD, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".